Skip to main content
Journal cover image

In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition.

Publication ,  Journal Article
Szlam, F; Tanaka, KA; Rumph, B; Bolliger, D; Levy, JH
Published in: Thromb Haemost
April 2010

Duke Scholars

Published In

Thromb Haemost

DOI

EISSN

2567-689X

Publication Date

April 2010

Volume

103

Issue

4

Start / End Page

863 / 865

Location

Germany

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Ticlopidine
  • Thrombin
  • Recombinant Proteins
  • Platelet Aggregation Inhibitors
  • Platelet Aggregation
  • Middle Aged
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Szlam, F., Tanaka, K. A., Rumph, B., Bolliger, D., & Levy, J. H. (2010). In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition. Thromb Haemost, 103(4), 863–865. https://doi.org/10.1160/TH09-09-0632
Szlam, Fania, Kenichi A. Tanaka, Brady Rumph, Daniel Bolliger, and Jerrold H. Levy. “In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition.Thromb Haemost 103, no. 4 (April 2010): 863–65. https://doi.org/10.1160/TH09-09-0632.
Szlam F, Tanaka KA, Rumph B, Bolliger D, Levy JH. In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition. Thromb Haemost. 2010 Apr;103(4):863–5.
Szlam, Fania, et al. “In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition.Thromb Haemost, vol. 103, no. 4, Apr. 2010, pp. 863–65. Pubmed, doi:10.1160/TH09-09-0632.
Szlam F, Tanaka KA, Rumph B, Bolliger D, Levy JH. In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition. Thromb Haemost. 2010 Apr;103(4):863–865.
Journal cover image

Published In

Thromb Haemost

DOI

EISSN

2567-689X

Publication Date

April 2010

Volume

103

Issue

4

Start / End Page

863 / 865

Location

Germany

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Ticlopidine
  • Thrombin
  • Recombinant Proteins
  • Platelet Aggregation Inhibitors
  • Platelet Aggregation
  • Middle Aged
  • Male
  • Humans